OS Fund LLC is a U.S.-based venture capital firm that focuses on investing in seed and early-stage businesses. The firm primarily targets innovative companies in the biotechnology, synthetic biology, and life sciences sectors. OS Fund typically participates in Series A, Seed, and Series B rounds, with investments ranging from early-stage funding to more substantial growth capital.
Notable portfolio companies include Ginkgo Bioworks, Human Longevity, Eat Just, and Synthego. The firm is known for its hands-on investment philosophy, providing not just capital but also strategic guidance and operational support to its portfolio companies. Key decision-makers at OS Fund bring a wealth of experience from various high-impact ventures, ensuring that their investments are well-supported for long-term success.
OS Fund - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
Total Investments30
Current Portfolio Count18
Total Portfolio Exits1
Top Investment Stages
Series A11 (37.9%)
Seed8 (27.6%)
Series B8 (27.6%)
Series C1 (3.4%)
Series D1 (3.4%)
Stage Mix
Series A 38%Seed 28%Series B 28%Series C 3%Series D 3%
Concentration shown as share of disclosed investments by stage.
OS Fund - Classification
- Also Known As
- OS Fund LLC
- NAICS
- 520000Finance and Insurance
- 523000Securities, Commodity Contracts, and Other Financial Investments and Related Activities
- 523900Other Financial Investment Activities
- 523990All Other Financial Investment Activities
- 523999Miscellaneous Financial Investment Activities
- SIC
- 6700Holding And Other Investment Offices
- 6790Miscellaneous Investing
- 6799Investors, Not Elsewhere Classified
Show 6 more industry codes
- NAICS
- 525000Funds, Trusts, and Other Financial Vehicles
- 523910Miscellaneous Intermediation
- 523940Portfolio Management and Investment Advice
- SIC
- 6000Depository Institutions
- 6720Investment Offices
- 6722Management Investment Offices, Open-end